Inventor · disambiguated record
Michael Tesar
Also filed as: TESAR MICHAEL · TESAR MICHAEL G
23 granted patents·13 pending applications·735 citations·filing 1996–2024
96Inventor score
Top patents by PatentIndex Score
36 records- 0197US8088896B2Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38TESAR MICHAEL·Filed 2006·Granted Jan 3, 2012·96 cites·40 claims
- 0296US9468678B2Method of producing 4-1BB binding molecules and associated nucleic acidsPFIZER·Filed 2014·Granted Oct 18, 2016·81 cites·9 claims
- 0396US8821867B24-1BB binding moleculesPFIZER·Filed 2012·Granted Sep 2, 2014·126 cites·14 claims
- 0496US8263746B2Anti-CD38 human antibodies and uses thereofTESAR MICHAEL·Filed 2005·Granted Sep 11, 2012·87 cites·28 claims
- 0594US9758590B2Anti-CD38 human antibodies and uses thereofMORPHOSYS AG·Filed 2015·Granted Sep 12, 2017·15 cites·3 claims
- 0694US8337850B24-1BB binding moleculesAHRENS BIANCA·Filed 2011·Granted Dec 25, 2012·159 cites·7 claims
- 0790US9193799B2Fully human therapeutic antibodies specific for human CD38MORPHOSYS AG·Filed 2013·Granted Nov 24, 2015·10 cites·40 claims
- 0889US9200061B2Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3iTESAR MICHAEL·Filed 2011·Granted Dec 1, 2015·17 cites·15 claims
- 0989US5867920AHigh speed infrared/convection dryerMEGTEC SYS INC·Filed 1997·Granted Feb 9, 1999·43 cites·11 claims
- 1088US2024309109A1Generation and profiling of fully human therapeutic antibodies specific for human cd38MORPHOSYS AG·Filed 2024·Application pending·0 cites
- 1186US11059902B2Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38MORPHOSYS AG·Filed 2018·Granted Jul 13, 2021·1 cites·7 claims
- 1286US10184005B2Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38MORPHOSYS AG·Filed 2015·Granted Jan 22, 2019·4 cites·24 claims
- 1384US8486394B2Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38TESAR MICHAEL·Filed 2011·Granted Jul 16, 2013·5 cites·17 claims
- 1482US11510972B2Bispecific EGFR/CD16 antigen-binding proteinAFFIMED GMBH·Filed 2020·Granted Nov 29, 2022·1 cites·16 claims
- 1581US10640568B24-1BB binding moleculesPFIZER·Filed 2018·Granted May 5, 2020·1 cites·11 claims
- 1679US11939395B2Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38MORPHOSYS AG·Filed 2021·Granted Mar 26, 2024·0 cites·6 claims
- 1779US11001633B2NK cell engaging antibody fusion constructsAFFIMED GMBH·Filed 2019·Granted May 11, 2021·1 cites·14 claims
- 1878US7521047B2Human polypeptides causing or leading to the killing of cells including lymphoid tumor cellsGPC BIOTECH AG·Filed 2001·Granted Apr 21, 2009·11 cites·65 claims
- 1978US2024294647A1Uses of nk cell engaging antibody fusion constructs for treatmentsAFFIMED GMBH·Filed 2024·Application pending·0 cites
- 2077US6213758B1Burner air/fuel ratio regulation method and apparatusMEGTEC SYS INC·Filed 1999·Granted Apr 10, 2001·46 cites·8 claims
- 2173US12076384B2Bispecific EGFR/CD16 antigen-binding proteinAFFIMED GMBH·Filed 2022·Granted Sep 3, 2024·0 cites·17 claims
- 2266US2021253698A1Uses of nk cell engaging antibody fusion constructs for treatmentsAFFIMED GMBH·Filed 2021·Application pending·0 cites
- 2364US7033544B2Determination of supplemental fuel requirement and instantaneous control thereof involving regenerative thermal oxidationMEGTEC SYS INC·Filed 2001·Granted Apr 25, 2006·6 cites·4 claims
- 2464US2016369000A14-1bb binding moleculesPFIZER·Filed 2016·Application pending·0 cites
- 2563US6067726AHigh speed infrared/convection dryerMEGTEC SYS INC·Filed 1999·Granted May 30, 2000·14 cites·3 claims
- 2663US2018215832A1Anti-cd38 human antibodies and uses thereforMORPHOSYS AG·Filed 2018·Application pending·0 cites
- 2761US2009325290A1Human polypeptides causing or leading to the killing of cells including lymphoid tumor cellsNAGY ZOLTAN·Filed 2009·Application pending·0 cites
- 2858US2012189622A1Anti-cd38 human antibodies and uses thereofTESAR MICHAEL·Filed 2012·Application pending·0 cites
- 2958US2016200828A1Anti-cd38 human antibodies and uses thereofMORPHOSYS AG·Filed 2016·Application pending·0 cites
- 3054US2015232571A1Anti-cd38 human antibodies and uses thereforMORPHOSYS AG·Filed 2015·Application pending·0 cites
- 3149US9873733B2Anti-staphylococcal antibodiesMORPHOSYS AG·Filed 2013·Granted Jan 23, 2018·0 cites·10 claims
- 3246US2009123950A1Generation And Profiling Of Fully Human Hucal Gold®-Derived Therapeutic Antibodies Specific For Human CD38MORPHOSYS AG·Filed 2006·Application pending·0 cites
- 3345US5762880AOperational process and its improved control system of a secondary air burnerMEGTEC SYS INC·Filed 1996·Granted Jun 9, 1998·11 cites·12 claims
- 3443US2004019187A1Immunomodulatory human mhc class II antigens-binding polypeptidesFiled 2001·Application pending·0 cites
- 3537US2018057601A1Novel humanized adam17 antibodyPF MEDICAMENT·Filed 2016·Application pending·0 cites
- 3632US2011165170A1Osteopontin antibodiesPFIZER·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Tesar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →